⌘K
Loading ticker…
VolitionRx Limited · Healthcare · Pharmaceutical Products
As of 2026-06-26, VolitionRx Limited (VNRX) has a 3-month relative strength percentile of 3 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 24. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.7%, relative volume 0.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
VNRX is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -43.1% / -77.0%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VNRX Jan avg: 15.04% median: 6.57% win: 75% σ: 22.51% n: 4 2022-04-12 → 2026-05-29 | VNRX Feb avg: -11.91% median: -13.29% win: 25% σ: 13.01% n: 4 2022-04-12 → 2026-05-29 | VNRX Mar avg: -10.12% median: -6.61% win: 0% σ: 8.57% n: 4 2022-04-12 → 2026-05-29 | VNRX Apr avg: -8.54% median: -11.00% win: 40% σ: 19.99% n: 5 2022-04-12 → 2026-05-29 | VNRX May avg: -6.17% median: -7.17% win: 40% σ: 10.38% n: 5 2022-04-12 → 2026-05-29 | VNRX Jun avg: 1.41% median: -12.30% win: 25% σ: 33.40% n: 4 2022-04-12 → 2026-05-29 (current) | VNRX Jul avg: -2.70% median: -2.29% win: 25% σ: 10.29% n: 4 2022-04-12 → 2026-05-29 | VNRX Aug avg: -1.77% median: 0.45% win: 50% σ: 12.22% n: 4 2022-04-12 → 2026-05-29 | VNRX Sep avg: -20.64% median: -18.03% win: 0% σ: 17.96% n: 4 2022-04-12 → 2026-05-29 | VNRX Oct avg: 3.49% median: 1.85% win: 50% σ: 34.73% n: 4 2022-04-12 → 2026-05-29 | VNRX Nov avg: 4.54% median: 8.83% win: 50% σ: 23.59% n: 4 2022-04-12 → 2026-05-29 | VNRX Dec avg: -9.38% median: -9.53% win: 25% σ: 9.84% n: 4 2022-04-12 → 2026-05-29 |